Clinical trials with Pseudomonas exotoxin immunotoxins.
Pai
L H
LH
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Pastan
I
I
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D005098:Exotoxins / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D000922:Immunotoxins / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D011550:Pseudomonas aeruginosa; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D005098:Exotoxins; D000922:Immunotoxins; D011993:Recombinant Fusion Proteins